About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, May 15th, 2014

The QualityStocks
Daily Stock List


Revolutions Medical Corp. (RMCP)

BUYINS.NET, OtcWizard, Penny Dreamers, TradeThesePicks, Investors News Source, Penny Stocks VIP, and AllPennyStocks reported previously on Revolutions Medical Corp. (RMCP), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Revolutions Medical Corp. engages in the design, development, and commercialization of auto retractable vacuum safety syringes. Its commitment is to developing and distributing new products and tools for the medical industry, whether internally or by way of acquisitions. The Company operates in two areas. One is safety-engineered medical devices, including its RevVac™ safety syringe. The other is medical imaging enhancement. This includes proprietary software solutions that considerably enhance the ability of medical professionals to use standard MRI images for diagnosis assistance. Revolutions Medical has its headquarters in Charleston, South Carolina.

The Company’s RevVac™ safety syringe uses vacuum technology to retract the needle into the plunger after use. The syringe cannot be reused once the vacuum is activated. Revolutions Medical believes that its safety syringe should essentially eliminate accidental needle stick injuries. Additionally, it believes it will help in reducing the spread of contagious diseases. The Company also believes that with the help of government regulatory initiatives and individual state law reforms the safety syringe market will grow in the foreseeable future domestically and internationally.

Revolutions Medical is working on developing, enhancing, and securing its proprietary MRI software tools for commercial launch. It believes that once clinical application validations using its MRI software suite of products, including RevColor, RevDisplay, and Rev3D directed at concussions, stroke, Alzheimer's and breast disease are achieved, these products could ultimately help in the enhanced diagnosis, detection, and monitoring of such diseases and afflictions.

Moreover, Revolutions Medical has commenced sales of its 3ml RevVac™ safety syringe through introducing and signing distributors, advertisements through its online sales program, attendance at many industry trade shows and direct marketing campaigns. It expects to be in full scale production by the third quarter of 2014 for its 1ml, 5ml and 10ml RevVac™ safety syringes. When all sizes of the RevVac™ safety syringe are in production, Revolutions Medical believes that it can ship 50 million RevVac™ safety syringes for the following twelve month period.

Revolutions Medical Corp. (RMCP), closed Thursday's trading session at $0.011, up 37.50%, on 1,209,500 volume with 27 trades. The average volume for the last 60 days is 305,847 and the stock's 52-week low/high is $0.0071/$0.09.

Solar3D, Inc. (SLTD)

MoneyTV, PennyStocks24, Penny Stock Craze, InvestorSoup, Stock Preacher, Pumps and Dumps, and Penny Stocks Finder reported earlier on Solar3D, Inc. (SLTD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Solar3D, Inc. is a foremost provider of solar power solutions and the developer of a proprietary high efficiency solar cell. The Company’s technology division is developing a patent-pending three-dimensional solar cell technology to maximize the conversion of sunlight into electricity. Solar3D has applied for patents covering the pioneering three-dimensional solar cell technology. The Solar3D Cell collects sunlight from a wide angle and lets light bounce around in three-dimensional microstructures on the solar cell surface. Solar3D has its headquarters in Santa Barbara, California.

The Company’s mission is to further the widespread adoption of solar power through deploying affordable, state-of-the-art systems and developing inventive new solar technologies. Its solar cell technology employs the three-dimensional design to trap sunlight inside micro-photovoltaic structures where photons bounce around until they undergo conversion into electrons. A distinctive wide-angle light collection feature on the cell surface permits the collection of sunlight over an array of angles during the day.

The design of this next generation solar cell is to be substantially more efficient, with the objective of attaining a lower cost per watt. The expectation is that the Company’s three-dimensional technology will combine thin-film and thick-film technologies to achieve the high efficiencies of crystalline at the lower cost of thin film. Solar3D is entering the final phase of the fabrication of the third generation prototype of its new solar cell. The Company has started optimizing the elements of its cutting-edge solar cell technology to maximize power output.

Solar3D has its SUNworks division. The SUNworks division centers on the design, installation and management of solar power systems for commercial, agricultural, and residential customers. SUNworks is one of the fastest growing solar systems providers in the State of California. SUNworks has delivered hundreds of 2.5 kilowatt to 1-megawatt commercial systems and has the capability of providing systems as large as 25 megawatts. 

Recently, Solar3D announced that solar systems sales by SUNworks' newly launched residential division through the first four months of 2014 are approaching $1 million per month. Additionally, homeowners report an average savings of 80 percent off their electric bills. Solar3D indicated that residential solar systems may account for as much as 50 percent of its 2014 revenues.

Solar3D, Inc. (SLTD), closed Thursday's trading session at $0.077, down 3.75%, on 1,946,340 volume with 164 trades. The average volume for the last 60 days is 1,391,095 and the stock's 52-week low/high is $0.0115/$0.158.

OriginOil, Inc. (OOIL)

StockHideout, Stock Roach, PennyStocks24, Pumps and Dumps, and SuperStockTips reported this month on OriginOil, Inc. (OOIL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB listed OriginOil, Inc. is the developer of a unique energy production process for harvesting algae and cleaning up oil & gas water. This process operates at the first stage of extraction. The high-speed and chemical-free process can be embedded in other systems to improve performance. OriginOil has developed an innovative process for removing up to 99 percent of contaminants from the very large quantities of water used by the oil & gas, algae, and other water-intensive industries. OriginOil is based in Los Angeles, California.

For the oil & gas industry, the Company is helping clean up produced water and recycle fracking water to reduce harm to the environment and lower costs. For the developing algae industry, it is making large-scale harvest possible. Moreover, in aquaculture, OriginOil is helping improve yields and making seafood healthier through significantly reducing the levels of toxic ammonia and bacteria in water.

The basis of OriginOil's CLEAN-FRAC process is on its Electro Water Separation™ (EWS) technology. This technology efficiently removes oils, suspended solids, insoluble organics, and bacteria from produced or 'frac flowback' water, on a continuous flow basis and without the use of chemicals. EWS is the high-speed, chemical-free process to clean up large quantities of water.

The Company’s EWS works in two parts. First, contaminated water enters the first stage, Electro-Coagulation (EC). In this stage, electrical impulses are applied in long tubes, causing the organic contaminants to coagulate, or “clump” together. In 2009, OriginOil branded this stage Single-Step Extraction™. Second, the clumped-up material travels into a tank where electrical pulses generate a cloud of micro-bubbles that gently lifts the concentrate to the surface for harvesting.

Yesterday, OriginOil announced plans to launch a product line that can treat frack water from end to end. The basis of the product, CLEAN-FRAC™, is on the Company’s P1000 platform. The design of this platform is to process 1,000 barrels per day of frac flowback and produced water. In addition, OriginOil licensee Pearl H20 has scheduled the installation of a commercial-scale three-quarter barrel per minute system in California’s Monterey Formation. Called Pearl Blue, the system incorporates OriginOil’s EWS Petro™ process at the first stage, to help effectively and economically treat frac flowback water for immediate reuse.

OriginOil, Inc. (OOIL), closed Thursday's trading session at $0.1825, down 2.93%, on 422,003 volume with 86 trades. The average volume for the last 60 days is 357,919 and the stock's 52-week low/high is $0.1575/$0.69.


BUYINS.NET, Greenbackers, OTCPicks, Stock Guru, and Real Pennies reported earlier on PAID, Inc. (PAYD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Founded in 1999, PAID, Inc. offers turnkey online tools and services that enable its customers to customize a solution that is right for them. The Company offers AuctionInc™ online shipping calculation and shopping cart software employing its patented technology to streamline ecommerce. PAID lists on the OTC Markets’ OTCQB. The Company has its corporate head office in Westborough, Massachusetts.

PAID created the above-mentioned proprietary service AuctionInc™. This is a suite of online shipping and tax management tools providing accurate shipping and tax calculations and packaging algorithms, which provide customers with the best possible shipping and tax solutions.

The Company filed for a patent before introducing it to the public in April of 2002. PAID obtained its first patent on the shipping calculator in January of 2008. It obtained the second patent in April of 2011, the third patent in January of 2013, and the fourth patent in August of 2013. The product is modular based.

PAID was established focusing on web-development and online auctions. The Company offers entertainers and businesses total web-presence and related services. PAID supports and manages clients’ official websites and fan-community services. This includes e-commerce, VIP ticketing, live event fan experiences, user-generated content, client content publishing and distribution, fan forums, social network management, social media marketing, customer data capture, management and analysis.

This past January, PAID announced that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,635,150 to PAID on January 22, 2014. The patent adds to the Company’s existing patent portfolio that includes patent numbers 8,521,642, 8,352,357, 7,930,237, 7,324,968 titled "Method and System for Improved Online Auction." All of these patents relate to the real-time calculation of shipping, insurance, and taxes online. 

Recently, PAID’s Board of Directors announced that it added Mr. Terry Fokas to the Board of Directors, effective immediately. Mr. Fokas brings substantial knowledge in patent licensing and managing intellectual property to PAID. He is the President and Chief Executive Officer of Parallel Networks, managing all facets of the company's software patent enforcement and licensing activities.

PAID, Inc. (PAYD), closed Thursday's trading session at $0.11, down 9.54%, on 813,900 volume with 44 trades. The average volume for the last 60 days is 278,112 and the stock's 52-week low/high is $0.068/$0.26.

GlyEco, Inc. (GLYE)

PennyStocks24, RedChip, and Greenbackers reported recently on GlyEco, Inc. (GLYE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

GlyEco, Inc. is a sustainable glycol technologies leader with corporate headquarters in Phoenix, Arizona. The Company is a green chemistry enterprise with a patent-pending technology for transforming hazardous waste into green products. This technology enables its clients to handle the removal of their waste glycol in a responsible and environmentally safe manner. GlyEco’s shares trade on the OTC Markets’ OTCQB.

GlyEco Technology™ has the unique ability to clean the polluted glycols from all five waste-producing industries. These industries are HVAC (heating, ventilation, and air conditioning), Textiles, Automotive, Airline and Medical. The technology recycles waste glycol to meet ASTM Type 1 specifications. This is the same level of purity expected of refinery-grade glycols. Consequently, GlyEco’s clients can treat glycols as a more sustainable resource, recycling and re-using waste glycols continually.

The GlyEco Technology™ solution gives its clients a method to reduce waste while caring for the environment, and while reducing their costs. The Company’s technology removes pollutants such as organic acids, esters, and high dissolved solids.

GlyEco has started its second phase of expansion at its New Jersey processing center. This is to meet increasing customer demand for its refinery-grade recycled glycol. The upgrades now taking place will further expand GlyEco’s waste glycol processing capacity and storage capabilities. Additional on-site storage enables the Company to increase its batch processing flexibility, which GlyEco believes will lead to better margins.

In late March, GlyEco announced that it completed the acquisition of MMT Technologies. GlyEco completed initial upgrades to the MMT Technologies facility in July of 2013. This included installation of an improved vacuum distillation system and advanced post-treatment equipment. Furthermore, overall processing capacity has been increased by more than 10,000 gallons. The improved processing center has been in production since August 2013. MMT Technologies is a glycol processing center in Lakeland, Florida.

This week, GlyEco announced its financial results for the first quarter ended March 31, 2014.

First quarter highlights include revenue increasing 34 percent year-over-year to $1.7 million. This is up from $1.2 million in 2013. Net equipment assets increased 31 percent to $7.2 million, up from $5.5 million at year-end 2013. Stockholders' equity increased 6 percent to $11.9 million. This represents an increase from $11.2 million at year-end 2013.

GlyEco, Inc. (GLYE), closed Thursday's trading session at $0.80, down 2.44%, on 83,404 volume with 44 trades. The average volume for the last 60 days is 71,713 and the stock's 52-week low/high is $0.7701/$1.40.


The QualityStocks
Company Corner


Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.107, up 1.90%, on 120,700 volume with 10 trades. The stock’s average daily volume over the past 60 days is 361,064, and its 52-week low/high is $0.004/$0.03.

Pan Global Corp. today updated shareholders concerning the 5.7MW small-hydro plant the Company is in the process of acquiring in northern India ("Project Badyar") pursuant to its staggered acquisition of Regency Yamuna Energy Limited (RYEL). Final construction of Project Badyar, according to RYEL, is being divided into two final stages, pre-commercial operation date ("Pre-COD") and post-commercial operation date ("Post-COD"). Pre-COD is anticipated to be completed as major civil works, including, but not limited to, construction of the Diversion Trench Weir structure, come to a close, barring any adverse weather conditions or other unforeseen circumstances.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global, Corp. Shareholder Update: Anticipated Two Stage Completion of Small-Hydro Plant and Connection to Power Grid

Pan Global, Corp. Comments on Industry Report That the Global Green Energy Market Is Expected to Reach USD $831.99 Billion in 2019

Pan Global, Corp. Announces Positive Initial Site Visits to and Inspections of First Small-Hydro Plant Project in Northern India

Armco Metals Holdings, Inc. (AMCO)

The QualityStocks Daily Newsletter would like to spotlight Armco Metals Holdings, Inc. (AMCO). Today, Armco Metals Holdings, Inc. closed trading at $0.2598, off by 4.49%, on 173,492 volume with 128 trades. The stock’s average daily volume over the past 60 days is 549,710, and its 52-week low/high is $0.18/$0.58.

Armco Metals Holdings, Inc. today announced that it will release its first quarter end 2014 financial results on Tuesday, May 20, 2014, with a conference call to take place at 5:00 pm EST. To attend the call, please use the Conference Line Dial-In in the U.S. (1-877- 407- 9210); or the International Dial-In number (1-201-689-8049). When prompted, ask for the "Armco Metals call" and/or be prepared to provide the conference ID# 13582975. Webcast link: http://www.investorcalendar.com/IC/CEPage.asp?ID=172779 The playback of the webcast can be accessed until 08/20/2014.

Armco Metals Holdings, Inc. (AMCO), since its founding 10 years ago, has worked tirelessly to create low-cost, high-quality solutions to meet steel industry demands and achieve its goal to become the largest scrap steel recycler in China. The company operates through five subsidiaries located in key regions throughout the country to source, import, process, and distribute quality, environmentally friendly recycled scrap steel, as well as metal and non-ferrous metal ore.

Subsidiaries Armco Metals International, Ltd., Armco (Lianyungang) Renewable Metals, Inc., Armet (Lianyungang) Holdings, Inc., Henan Armco & Metawise Trading Co., Ltd., Armco Metals (Shanghai) Holding, Ltd. support Armco Metal’s overarching corporate mission and operate to provide the country’s steel production industry with sustainable, responsible solutions to its material needs. Aligned with China’s green initiatives, Armco Metals and its subsidiaries are helping the government reach its scrap metal consumption goal of 20% by 2015.

Leveraging long-standing relationships with more than 10 international metal suppliers, more than 100 small- and medium-sized Chinese steel production companies, and some of the country’s large state-run foundries, Armco Metals benefits from a steady and dependable supply of demand for the company’s high-quality product known for excellent market values.

Armco Metals’ management team has established a unique approach to business and environment by providing responsible solutions based on environmentally friendly practices; reliable, cost-effective sourcing; and quality metal products. Backed by more than 10 years of industry experience, company executives have successfully positioned the company as credible, dependable partner for customers, suppliers, and investors within the steel production market. Disclaimer

Armco Metals Holdings, Inc. Company Blog

Armco Metals Holdings, Inc. News:

Armco Metals Holdings Inc. to Host First Quarter End 2014 Earnings Conference Call on Tuesday May 20, 2014 at 5:00 p.m. EST

Armco Metals Holdings Enters Into Agreement to Acquire 100% of Draco Resources, Inc.

Armco Metals Holdings Announces Financial Results for the Fourth Quarter and Full Year of 2013

Victory Energy Corp. (VYEY)

The QualityStocks Daily Newsletter would like to spotlight Victory Energy Corp. (VYEY). Today, Victory Energy Corp. closed trading at $0.30, even for the day, on 2,650 volume with 6 trades. The stock’s average daily volume over the past 60 days is 7,329, and its 52-week low/high is $0.015/$0.51.

Victory Energy Corp. announced financial and operating results for the three months ended March 31, 2014 yesterday. Among the highlights are events such as revenues increasing 108% year-over-year to $194,983, successful completion of drilling in two (gross) wells during the quarter, VYEY's partnership (Aurora Energy Partners) that closed a $25 million credit facility with Texas Capital Bank, and securing of a $10 million capital line from Navitus Energy Group -- Victory's partner in Aurora.

Victory Energy Corp. (VYEY) is an independent, growth-oriented oil and gas company focused on growing proved reserves and cash-flow via the continued development of existing properties and the acquisition of new resource properties, primary located in the prolific Permian Basin of Texas and southeast New Mexico. The Company will source new capital to facilitate this growth by continuing to utilize an established pipeline of investors available through Aurora Energy Partners and additional third-party sources. The company is committed to creating long-term shareholder value by increasing oil reserves, lowering costs, boosting production volumes, and prudently managing the capital on its balance sheet.

The company is geographically focused onshore, with a primary emphasis on the Permian Basin of Texas and southeast New Mexico. Victory strategically utilizes both internal capabilities and strategic industry relationships to acquire non-operated working interest positions in low-to-moderate risk oil and gas prospects. Its focus is on oil or liquid-rich gas projects within longer-life reservoirs that offer competitive finding and development (F&D) costs per barrel of oil equivalent (BOE).

Victory’s carefully assembled management team has more than 120 years of direct and relevant oil and gas experience. The company also utilizes a team of third-party professionals on an as-needed basis. This team includes geologists for property evaluation and assessment and reservoir engineering resources for the analysis of current and new properties. Reserve reporting is performed by a third-party engineer located in Midland, Texas. Each independent operator utilized by the company also has their own array of experts.

As it executes its strategy, Victory will be targeting investment in larger working interest projects (10%-25% that are weighted toward oil and high-BTU natural gas. This approach of increasing economic interest should allow for improved returns through cost efficiencies derived from economies of scale. Lower expenses and additional capital will give the company added flexibility to invest in the development of its current proven undeveloped, possible, and probable reserves, while also allowing for additional oil and gas prospects and improved working interest positions. Disclaimer

Victory Energy Corp. Company Blog

Victory Energy Corp. News:

Victory Energy Announces First Quarter 2014 Results

Target Energy Limited Announces 10% Sale of Fairway Project for A$6.5m

Victory Energy Announces Acquisition of Fairway Project in West Texas

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.60, up 25.26%, on 29,000 volume with 13 trades. The stock’s average daily volume over the past 60 days is 4,189, and its 52-week low/high is $0.25/$0.89.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine

VistaGen Joins the Cardiac Safety Research Consortium

VistaGen Provides Update on $36 Million Strategic Financing Agreement

Innocent, Inc. (INCT)

The QualityStocks Daily Newsletter would like to spotlight Innocent, Inc. (INCT). Today, Innocent, Inc. closed trading at $0.007, up 6.06%, on 3,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,496, and its 52-week low/high is $0.0005/$0.092.

Innocent, Inc. (INCT) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.

The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Innocent aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.

Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Innocent has strategically added extensive technical guidance and field management experience.

Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Innocent is well positioned to generate substantial revenues in the short and long term future. Disclaimer

Innocent, Inc. Company Blog

Innocent, Inc. News:

Innocent Inc. Announces Letter to Shareholders

Innocent Inc. Announces New Joint Venture to Explore for Oil and Gas

Innocent, Inc. (INCT) is "One to Watch"


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





OTCBB Journal


Wall Street Resources

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251